克罗地亚新诊断女性患者乳腺癌症危险因素的区域差异

Q4 Medicine

Libri Oncologici Pub Date : 2019-01-29 DOI:10.20471/LO.2018.46.02-03.08

Katarina Vučić, T. Orešić, Karolina Habljak, Marija Kahlina, I. Kirac, M. Šekerija

{"title":"克罗地亚新诊断女性患者乳腺癌症危险因素的区域差异","authors":"Katarina Vučić, T. Orešić, Karolina Habljak, Marija Kahlina, I. Kirac, M. Šekerija","doi":"10.20471/LO.2018.46.02-03.08","DOIUrl":null,"url":null,"abstract":"1Department for Safety and Effi cacy Assessment of Medicinal Products, Agency for Medicinal Products and Medical Devices, Zagreb, Croatia; 2Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 3Croatian National Cancer Registry, Department for Malignant Diseases, Croatian Institute of Public Health, Zagreb and Andrija Štampar School of Public Health, University of Zagreb School of Medicine, Zagreb, Croatia","PeriodicalId":53700,"journal":{"name":"Libri Oncologici","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.20471/LO.2018.46.02-03.08","citationCount":"2","resultStr":"{\"title\":\"Regional differences of breast cancer risk factors in newly diagnosed female patients in Croatia\",\"authors\":\"Katarina Vučić, T. Orešić, Karolina Habljak, Marija Kahlina, I. Kirac, M. Šekerija\",\"doi\":\"10.20471/LO.2018.46.02-03.08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1Department for Safety and Effi cacy Assessment of Medicinal Products, Agency for Medicinal Products and Medical Devices, Zagreb, Croatia; 2Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 3Croatian National Cancer Registry, Department for Malignant Diseases, Croatian Institute of Public Health, Zagreb and Andrija Štampar School of Public Health, University of Zagreb School of Medicine, Zagreb, Croatia\",\"PeriodicalId\":53700,\"journal\":{\"name\":\"Libri Oncologici\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.20471/LO.2018.46.02-03.08\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Libri Oncologici\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20471/LO.2018.46.02-03.08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Libri Oncologici","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/LO.2018.46.02-03.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 2

摘要

1药品和医疗器械管理局药品安全和有效性评估部，克罗地亚萨格勒布；2克罗地亚萨格勒布Sestre milosrdnice大学医院中心肿瘤大学医院肿瘤外科；3克罗地亚国家癌症登记处，克罗地亚公共卫生研究所恶性疾病科，萨格勒布和萨格勒布大学医学院AndrijaŠtampar公共卫生学院，克罗地亚萨格勒布

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Regional differences of breast cancer risk factors in newly diagnosed female patients in Croatia

1Department for Safety and Effi cacy Assessment of Medicinal Products, Agency for Medicinal Products and Medical Devices, Zagreb, Croatia; 2Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 3Croatian National Cancer Registry, Department for Malignant Diseases, Croatian Institute of Public Health, Zagreb and Andrija Štampar School of Public Health, University of Zagreb School of Medicine, Zagreb, Croatia

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Libri Oncologici Medicine-Oncology

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： - Genitourinary cancer: the potential role of imaging - Hemoglobin level and neoadjuvant chemoradiation in patients with locally advanced cervical carcinoma